SALEM, N.H.—Sarcevic Ademir, the Vice President, CFO, and Treasurer of Standex International Corp (NYSE:SXI), recently sold shares of the company, according to a filing with the Securities and Exchange Commission. On November 20, Ademir sold 1,600 shares of Standex International at a weighted average price of $199.81, totaling approximately $319,696. Following this transaction, Ademir holds 18,086 shares in the company.
The shares were sold at varying prices between $199.50 and $200.305, as noted in the filing. Standex International, based in Salem, New Hampshire, operates in the refrigeration and service industry machinery sector.
In other recent news, Standex International Corporation has made strategic moves to expand its operations and bolster its financial metrics. The company recently acquired Custom Biogenic Systems, a Michigan-based manufacturer of cryogenic equipment, for $6.2 million. This acquisition is expected to contribute to Standex's earnings and enhance its North American manufacturing capabilities. Furthermore, Standex reported a 7.7% decline in sales for the fiscal first quarter of 2025, with a record gross margin above 40% and an operating margin near 16%. Standex also announced the acquisition of Amran Instrument Transformers and Narayan Powertech, a move anticipated to improve various financial metrics and expand Standex's reach into fast-growth markets. The total revenue for the fiscal first quarter stood at $170.5 million. As part of recent developments, Standex expects the Amran/Narayan Group to generate approximately $100 million in revenue in 2024, with an adjusted EBITDA margin exceeding 40%. The company is focusing on debt repayment and expects to improve operating margins and gross margins, aiming for the mid-20% range in the near future.
InvestingPro Insights
Standex International Corp (NYSE:SXI) has been showing strong market performance, with a year-to-date price total return of 28.31% and an impressive one-year price total return of 48.17% as of the latest data. This robust performance aligns with the recent insider selling activity, as executives often sell shares when they believe the stock price is favorable.
The company's financial health appears solid, with a market capitalization of $2.48 billion and a revenue of $706.33 million over the last twelve months as of Q1 2025. Despite a slight revenue decline of 5.22% over the same period, Standex maintains a healthy gross profit margin of 39.56% and an operating income margin of 15.61%, indicating efficient operations.
InvestingPro Tips highlight that Standex has raised its dividend for 13 consecutive years, demonstrating a commitment to shareholder returns. This is further supported by the company's dividend growth of 14.29% over the last twelve months. For investors seeking more insights, InvestingPro offers 15 additional tips for Standex International, providing a comprehensive analysis of the company's financial position and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.